News

Published on 29 Mar 2024 on GuruFocus.com via Yahoo Finance

Insider Sell: COO Jennifer Jarrett Sells 11,551 Shares of Arcus Biosciences Inc (RCUS)


Article preview image

Arcus Biosciences Inc (NYSE:RCUS), a company focused on the discovery, development, and commercialization of cancer immunotherapies, has reported an insider sell according to the latest SEC filings. Chief Operating Officer Jennifer Jarrett sold 11,551 shares of the company on March 27, 2024. The transaction was disclosed in a Form 4 filing with the Securities and Exchange Commission.

The insider, Jennifer Jarrett, has been active in the market over the past year, selling a total of 196,515 shares and making no purchases of the company's stock during that period. The recent sell by the insider contributes to a pattern observed over the last year, where insider transactions for Arcus Biosciences Inc have consisted of 2 insider buys and 13 insider sells.

NYSE.RCUS price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Arcus Biosciences Inc (RCUS) Q3 2024 Earnings Call Highlights: Strong Cash...

Arcus Biosciences Inc (RCUS) reports robust financial health and strategic advancements in...

GuruFocus.com · via Yahoo Finance 7 Nov 2024

What To Expect From Arcus Biosciences Inc (RCUS) Q3 2024 Earnings

Arcus Biosciences Inc (NYSE:RCUS) is set to release its Q3 2024 earnings on Nov 6, 2024. The...

GuruFocus.com · via Yahoo Finance 5 Nov 2024

Arcus Biosciences Inc (RCUS) Q2 2024 Earnings Call Highlights: Strategic...

Cash and Investments: $1 billion as of June 30, 2024.GAAP Revenue: $39 million for the second qua...

GuruFocus.com · via Yahoo Finance 8 Oct 2024

It's Unlikely That Arcus Biosciences, Inc.'s (NYSE:RCUS) CEO Will See A Huge Pay Rise This Year

Key Insights Arcus Biosciences' Annual General Meeting to take place on 6th of JuneSalary of US$6...

Simply Wall St. via Yahoo Finance 31 May 2024

Arcus Biosciences, Inc. (NYSE:RCUS) Reported Earnings Last Week And Analysts Are Already Upgrading...

Arcus Biosciences, Inc. (NYSE:RCUS) investors will be delighted, with the company turning in some...

Simply Wall St. via Yahoo Finance 12 May 2024

Arcus Biosciences, Inc. (NYSE:RCUS) Q1 2024 Earnings Call Transcript

Arcus Biosciences, Inc. (NYSE:RCUS) Q1 2024 Earnings Call Transcript May 8, 2024 Arcus Bioscience...

Insider Monkey via Yahoo Finance 9 May 2024

Will Arcus Biosciences, Inc. (RCUS) Report Negative Earnings Next Week? What You Should Know

The market expects Arcus Biosciences, Inc. (RCUS) to deliver a year-over-year increase in earning...

Zacks via Yahoo Finance 1 May 2024

Insider Sell: COO Jennifer Jarrett Sells 11,551 Shares of Arcus Biosciences Inc (RCUS)

Arcus Biosciences Inc (NYSE:RCUS), a company focused on the discovery, development, and commercia...

GuruFocus.com via Yahoo Finance 29 Mar 2024

Insider Sell: COO Jennifer Jarrett Sells 13,449 Shares of Arcus Biosciences Inc (RCUS)

Arcus Biosciences Inc (NYSE:RCUS), a company focused on the discovery, development, and commercia...

GuruFocus.com via Yahoo Finance 21 Mar 2024

Insider Sell: COO Jennifer Jarrett Sells 58,625 Shares of Arcus Biosciences Inc (RCUS)

Arcus Biosciences Inc (NYSE:RCUS), a company focused on creating and developing cancer immunother...

GuruFocus.com via Yahoo Finance 29 Feb 2024